Myovant Sciences
UEI: YWQRZ1GWHC35
• CAGE: 8S5W8
Overview
Parent Awardee
Company Description
Improving health of people everywhere - innovative treatments, science, and tech to address patient needs in psychiatry, oncology, urology, women's health, rare diseases, and cell & gene therapy.
Name
Myovant Sciences
Website
Headquarters
Brisbane, CA
United States
United States
Federal recipient
MYOVANT SCIENCES INC
(UEI YWQRZ1GWHC35, CAGE 8S5W8)
is headquartered in Brisbane CA.
Its primary registered NAICS is 325412 Pharmaceutical Preparation Manufacturing.
The corporation
was founded in January 2016 and
federally registered in
August 2020.
Federal Registration and Certifications
Legal Name
MYOVANT SCIENCES INC
Division Name
MYOVANT SCIENCES, INC
Division Number
MYOVANT SC
UEI
YWQRZ1GWHC35
CAGE Code
8S5W8
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 1, 2016
Initial Registration
Aug. 31, 2020
Last Registration
Dec. 9, 2023
Registration Activation
Dec. 30, 2022
Registration Expiration
Dec. 9, 2023
Fiscal Year End
March 31
Reported Entity Types
Foreign Owned
For Profit Organization
Manufacturer of Goods
For Profit Organization
Manufacturer of Goods
State of Incorporation
DE
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Accepts Credit Cards
No
People
Vendor contacts at Myovant Sciences
GSA Schedules and Price Lists
- Myovant Sciences
- PoP: 7/31/21 - 7/31/26
- Type: Pharmaceuticals and Drugs (FSS 65 I B)
- Myovant Sciences
- PoP: 2/15/21 - 7/31/21 (Ended)